Understanding the developmental mechanisms of humoral immunity against intranasal antigens is essential for the development of therapeutic approaches against air-borne pathogens as well as allergen-induced pulmonary inflammation. Follicular helper T (Tfh) cells expressing CXCR5 are required for humoral immunity by providing IL-21 and ICOS costimulation to activated B cells. However, the regulation of Tfh cell responses against intranasal antigens remains unclear. Here, we found that the generation of Tfh cells and germinal center B cells in the bronchial lymph node against intranasal proteinase antigens was independent of TGF-β. In contrast, administration of STAT3 inhibitor STA-21 suppressed the generation of Tfh cells and germinal center B cells.
INTRODUCTION
Induction of antigen-specific antibodies is one of the key features of adaptive immunity upon encountering environmental antigens including infectious agents as well as allergens. While the generation of high-affinity antibodies to infectious agents is beneficial to hosts, the production of IgE can trigger anaphylactic shock and allergic tissue inflammation (Gould et al., 2003; Gould and Sutton, 2008) . The generation of highaffinity antibodies and memory B cell requires help from T cells by facilitating germinal center reactions (Liu et al., 1992; MacLennan, 1994; Crotty, 2011) . In particular, our respiratory system is exposed to an external environment and continuously encounters various types of foreign antigens such as airborne pathogens, pollution, and allergens (Pauli et al., 1988; Albright and Goldstein, 1996) . However, the cellular and molecular mechanisms governing the development of germinal center reactions to airborne antigens remain unclear. Elucidating such mechanisms will pave the development of efficacious vaccines to airborne pathogens and therapeutic approaches for the treatment of allergic lung inflammation.
Upon antigenic stimulation, naïve CD4 + T cells can be differentiated into at least 5 distinct effector T cells including Th1, Th2, Th17, follicular helper T (Tfh), and Foxp3 + regulatory T cells depending on microenvironmental cytokine milieu (Dong, 2006; Cua and Tato, 2010; Nurieva and Chung, 2010) . Among them, Tfh cells are known to play a crucial role in facilitating germinal center reactions by providing IL-4 and IL-21 as well as ICOS costimulation to B cells. These 'helps' from Tfh cells trigger the survival and proliferation of B cells, isotype-switching of immunoglobulin, affinity maturation of immunoglobulin, and the differentiation of plasma cells and memory B cells from activated B cells (Breitfeld et al., 2000; Vinuesa et al., 2005; Crotty, 2011) . Cytokines from innate immune cells including IL-6, IL-12 and IL-27 have been identified to induce the initial differentiation of Tfh cells by inducing IL-21 via STAT3, along with other cytokines, in activated T cells (Batten et al., 2010; Eto et al., 2011) . In addition to these cytokine signals, interaction of the activated T cells with B cells activated with the same antigen at T:B border is required for the differentiation of Tfh
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Biomol Ther 24(3), 244-251 (2016) www.biomolther.org cells (Chang and Chung, 2014) . Aerosol allergens efficiently induce Th2 cell responses and the production of IgE and IgG1 in animal models of allergic inflammation. The involvement of Tfh cells as well as the requirement of pulmonary Tfh cells in this process is relatively unclear. Allergens and aerosol pathogens are known to induce the production of IL-6, a potent inducer of IL-21 (Doganci et al., 2005; Neveu et al., 2010; Rincon and Irvin, 2012) . Hence, Tfh cells are likely induced and play a crucial role in modulating antibody responses in allergic inflammation as well as in pulmonary infections.
Lung environment is unique in that it favors the differentiation of Th2 cells and Th17 cells rather than that of Th1 cells. For instance, Listeria monocytogenes infection via parental routes triggers Th1 cell dominant responses with little Th2 and Th17 cell responses (Pepper et al., 2010; Chung et al., 2013) . The same pathogen, however, induces Th17 dominant responses with little Th1 cells in the lung when administered via intranasal route. Similarly, protein antigens including allergens predominantly trigger Th2 cell responses in the lung while the same antigens elicit Th1 and Th17 cell responses (Lloyd and Hessel, 2010; Zhao et al., 2013) . The mechanisms by which lung environment preferentially induces Th2 and Th17 cells while suppressing Th1 cell responses are unclear; however, the differentiation of allergen-induced Th17 cells depends on TGF-β. In addition, the regulation of Tfh cell immunity in the lung remains to be determined.
In the present study, we aimed to dissect the kinetics of Tfh cells and germinal center reactions as well as molecular requirements of such immunity against intranasal antigens by using an allergen-induced animal model of lung inflammation. Our results indicate that Tfh cell responses preceded the development of germinal center B cell reactions as well as the production of allergen-specific immunoglobulins. In addition, the pulmonary Tfh cell responses were independent of TGF-β but depended on STAT3 in a T cell intrinsic manner.
MATERIALS AND METHODS

Mice
C57BL/6 mice were purchased from Orient (Gyeonggido, Republic of Korea). OT-II, B6.SJL (CD45.1) and Tcrb -/-mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). STAT3 flox/flox CD4-Cre mice were kindly provided by Drs. C. Dong (MD Anderson Cancer Center, Houston, TX, USA) and S. Akira (Osaka University, Osaka, Japan) and were crossed with OT-II to generate T cell-specific STAT3-deficient OT-II mice. All mice were maintained in the specific pathogen free facility at the vivarium of Seoul National University. All animal experiments were performed using a protocol approved by Institutional Animal Care and Use Committee Seoul National University (SNU-140602-2-2).
Allergen-induced lung inflammation
Mice were anesthetized with isoflurane (Piramal, Bethlehem, PA, USA) and were intranasally administered with a mixture of 7 μg of proteinase extracted from Aspergillus melleus (Sigma, St Louis, MO, USA) and 20 μg of Ovalbumin (Ova; Grade V, Sigma, St Louis, MO, USA) (Asp/Ova) in 50 μl of PBS (Katy, TX, USA) every two days for a total of five times (day 0, 2, 4, 6, 8) . Sixteen hours after the last challenge, all mice were euthanized and the bronchial lymph nodes, superficial cervical lymph nodes and sera were obtained for further analysis. For TGF-β neutralization experiments, mice were injected intraperitoneally with 200 μg of an anti-TGF-β neutralizing antibody (1D11, BioXCell, West Lebanon, NH, USA) or their corresponding IgG1 control (MOPC-21, BioXCell, West Lebanon, NH, USA) three times every two days (day 0, 2, 4). For STAT3 inhibition experiments, mice were treated with intraperitoneal injections of 0.5 mg/kg STA-21 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or vehicle every two days for 9 days (day 0, 2, 4, 6, 8) and were treated with intranasal injections of 0.25 mg/kg STA-21 or vehicle every other day for 9 days (day 1, 3, 5, 7).
Flow cytometry
For T cell analysis, the cells were stained with PerCP-Cy5.5-conjugated anti-CD4, and biotinylated anti-CXCR5 followed by PE-or APC-conjugated streptavidin. PerCP-Cy5.5-conjugated anti-CD45.1 and Pacific Blue-conjugated anti-CD45.2 were additionally used for surface staining. All antibodies were purchased from Biolegend (San Diego, CA, USA). These cells were permeabilized with a Foxp3 staining kit (eBioscience, San Diego, CA, USA), and further stained with APC-conjugated anti-Foxp3 (Biolgend, San Diego, CA, USA). For phenotypic analysis, FITC-conjugated anti-PD-1 (eBioscience, San Diego, CA, USA) was used. For B cell analysis, the cells were stained with APC-conjugated anti-B220 (Biolegend, San Diego, CA, USA), PE-conjugated anti-CD95 (eBioscience, San Diego, CA, USA), PerCP-Cy5.5-conjugated anti-CD138 (Biolegend, San Diego, CA, USA) and FITC-conjugated anti-GL7 (BD bioscience, San Jose, CA, USA). These cells were analyzed by FACSAria III or FACSVerse (BD bioscience, San Jose, CA, USA) and data were analyzed using software called Flowjo (TreeStar, Ashland, OR, USA).
ELISA
Sera from intranasally challenged mice with Asp/Ova were collected, and Ova-specific IgM, IgE, IgG1, IgG2b and IgG2c antibodies were measured by ELISA. Briefly, serum samples were added in a 3-fold or 5-fold serial dilution onto plates precoated with 5 μg/ml Ova. Ova-specific antibodies were detected with HRP conjugated goat anti-mouse IgM, IgE, IgG1, IgG2b, and IgG2c antibodies (Southern Biotechnology Associates, Birmingham, AL, USA). 
Adoptive transfer studies
RESULTS
Kinetic analysis of Tfh cell and germinal center B cell responses against intranasal allergens
As a first step to dissect germinal center reactions in the bronchus-associated lymphoid tissues (BALT) upon allergenic challenges, we employed an animal model of allergic asthma induced by Aspergillus protease and ovalbumin (Asp/Ova), as previously described Lim et al., 2013) . Groups of C57BL/6 mice were intranasally challenged with Asp/Ova every other day before lymphoid cells from bronchial lymph node (bLN) or superficial cervical lymph node (scLN) were analyzed for the frequencies of CXCR5 + germinal center B cells, and B220 -CD138 + plasma cells. As shown in Fig. 1A , B, the magnitudes of Tfh cells, germinal center B cells and plasma cells were all remarkably higher in the bLN than those in the scLN. Kinetic analysis of Tfh cell responses in the bLN showed that the frequency of Tfh cell peaked at day 7, and it gradually decreased afterward.
On the other hand, the frequencies of both germinal center B cells and plasma cells peaked on day 13 in the bLN, indicating that the Tfh cell responses preceded germinal center B cell responses by about 6 days in this experimental setting. Similar to the kinetics of germinal center B cells and plasma cells in the bLN, the serum levels of Ova-specific IgE, IgG1, IgG2b were highest at day 13 compared with those of day 3 and day 9 (Fig. 1C) . The levels of Ova-specific IgG2c appeared to be higher at day 9 than those of day 13. These results indicate that bLN is the lymphoid organ where active germinal center reactions occurred upon intranasal challenges of allergens and that the optimal time point to dissect germinal center reactions is between day 7 and day 13 in this experimental setting.
Effects of TGF-β blockade on pulmonary Tfh cell responses against intranasal allergens
We next sought to determine the factors that regulate the observed germinal center reactions in the bLN. TGF-β signal is required for the differentiation of Th17 cells and regulatory T cells; however, its role in the Tfh cell and germinal center responses has been controversial (McCarron and Marie, 2014; Schmitt et al., 2014; Marshall et al., 2015) . Administration of anti-TGF-β in mice challenged with intranasal Asp/Ova resulted in little differences in the frequencies of CXCR5 (Fig. 2 ). These results demonstrate that blockade of TGF-β had little impact in the generation of Tfh cell responses as well as germinal center B cell responses.
A STAT3 inhibitor STA-21 dampens pulmonary Tfh cell responses
Our recent study showed that STAT3 differentially regulates pulmonary Th17 and Th2 cells (Lim et al., 2015) . STAT3 signal in T cells is known to mediate the generation of Tfh cells (Nurieva and Chung, 2010) . Therefore, we next asked if inhibition of STAT3 impacts the germinal center reactions generated in response to intranasal allergens. Mice were intranasally challenged with Asp/Ova and were additionally administered with a STAT3 inhibitor STA-21 or vehicle. Although it did not reach statistical significance, Fig. 3A, 3B shows the frequency of CXCR5 + PD-1 + Tfh cells was lower in the STA-21-treated group than that in the vehicle-treated group. Similarly, the frequencies of GL7 + CD95
+ germinal center B cells and B220 -CD138 + plasma cells were significantly decreased in the STA-21 treated group (Fig. 3C, 3D ). These data indicate that a STAT3 inhibitor STA-21 suppressed the generation of Tfh cell and germinal center B cell responses in the bLN upon intranasal allergenic challenges.
Ablation of STAT3 in T cells blocks pulmonary Tfh cell responses and germinal center reactions
The observation that a STAT3 inhibitor suppressed pulmonary Tfh cell and germinal center B cell responses prompted us to determine the role of T cell-intrinsic STAT3 in the germinal center reactions to intranasal allergens. To determine the function of STAT3 in CD4 + T cell during antigen-specific responses in vivo, we crossed OT-II mice harboring T cell receptor specific to Ova323-339 in the context of MHC II with mice lacking STAT3 in CD4 + cells (CD4 We next sought to determine whether STAT3-deficiency in CD4 + T cell also impacted the magnitude of germinal center responses. As shown in Fig. 5A , 5B, there was a marked decrease in the percentage of GL7 + CD95
+ germinal center B cells in the recipients of CD4 STAT3-/-OT-II T cell compared with that in the recipients of CD4 STAT3+/+ OT-II T cell. Similarly, the percentage of B220 -CD138 + plasma cells was lower in the former group although it was not statistically significant. More importantly, we also found a significant reduction in the amounts of Ova-specific IgM, IgG2b and IgG2c as well as, to less extent, IgG1 antibodies in the former mice (Fig. 5C ). Collectively, these data indicate that the STAT3 signal in antigen-specific CD4 + T cells not only mediated Tfh cell differentiation but also facilitated germinal center B cell responses and subsequent antibody production in response to intranasal allergens in vivo.
T cell intrinsic STAT3 is required for the differentiation of pulmonary Tfh cells in vivo
To further examine if the observed defective Tfh cell responses were due to T cell-intrinsic function of STAT3 or the lack of appropriate signals from STAT3-sufficient T cells, we mixed STAT3-sufficient OT-II T cells (CD45. (Fig. 6 ). These data indicate that T cell intrinsic STAT3 signal was crucial for the differentiation of naïve T cells into Tfh cells in vivo in the bLN upon intranasal allergenic challenges.
DISCUSSION
Regulatory mechanism of germinal center reactions in the BALT remains unclear. In the present study, we found that the generation of Tfh cells and germinal center B cell responses was independent of TGF-β. By contrast, T cell intrinsic STAT3 signal appeared to be necessary for the pulmonary Tfh cells and germinal center B cell responses since (i) a STAT3 inhibitor STA-21 decreased the frequencies of Tfh cells and germinal center B cells in the bLN, (ii) STAT3-deficient T cells failed to be differentiated into Tfh cells in the bLN, (iii) Tcrb -/-recipients of STAT3-deficient T cells exhibited significantly reduced germinal center B cells and plasma cells, and diminished levels of allergen-specific IgG and IgE in an animal model of allergic lung inflammation induced by intranasal fungal protease allergens. Our findings suggest that targeting STAT3 signaling in T cells might be effective to suppress the production of unnecessary humoral immunity to inhaled allergens.
TGF-β signal is required for the differentiation of Th17 cells and induced regulatory T cells. TGF-β has been originally suggested to be indispensable for the generation of Tfh cells in vivo (Nurieva et al., 2008) , or even inhibit Tfh cell immunity (McCarron and Marie, 2014) . However, a recent study showed that TGF-β signal enhances the differentiation of human Tfh cells by promoting the generation of Bcl6 + RORgT + T cells upon STAT3 and STAT4 activation (Schmitt et al., 2014) . Furthermore, TGF-β signal has been shown to facilitate Tfh cells during acute viral infection by attenuating IL-2 signals (Marshall et al., 2015) . In the present study, however, administration of neutralizing antibody to TGF-β exhibited little effects on the frequencies of Tfh cells, germinal center B cells, and plasma cells. Hence, it is likely that blockade of TGF-β can minimally affect the generation of allergen-specific immunoglobulins in the BALT.
STAT3 activation is a common requirement for the differentiation of Th17 cells and Tfh cells (Nurieva et al., 2008) . STAT3 has been shown to antagonize STAT5 signal by competing their common binding sites (Yang et al., 2011) during Th17 cell differentiation. STAT5 signal is also a negative regulator of Tfh cell differentiation (Johnston et al., 2012; Nurieva et al., 2012) , suggesting that the balance between STAT3 and STAT5 is crucial for the Tfh cell generation. Thus enhancement of STAT5 signaling pathway or blockade of STAT3 possibly attenuates Tfh cell immunity. Indeed, we observed that administration of a STAT3 inhibitor significantly decreased the size of germinal center reactions in the bLN. Mechanistic studies convincingly showed that blockade of STAT3 signal in T cells was sufficient to significantly attenuate the generation of Tfh cells, germinal center B cells, plasma cells as well as the production of allergen-specific IgG and IgE. Our recent study showed that STAT3 deficiency significantly increased the frequency of pulmonary Th1 cells (Lim et al., 2015) . Thus, STAT3 suppresses Th1 cells but promotes Tfh cells and Th17 cells in the BALT in response to intranasal allergens.
Production of allergen-specific immunoglobulin including IgE is known to mediate local and systemic anaphylactic responses by stimulating degranulation of mast cells (Kemp and Lockey, 2002; Akin, 2015) . Suppression of allergen-specific humoral responses might provide beneficial therapeutic ef-www.biomolther.org fects in patients with allergy. Our findings propose that inhibition of STAT3 signaling in T cells can be a promising target in the development of therapeutic approaches for the treatment of allergic lung inflammation including allergic asthma.
